Stock Events

Stock Events

Entheon Biomedical 

0
0
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-208,951.29Net Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Compass Pathways
CMPS
Mkt Cap1.84B
Compass Pathways operates in the psychedelic medicine sector, focusing on psilocybin therapy for depression, similar to Entheon's focus on psychedelic therapies.
AtaiBeckley
ATAI
Mkt Cap2.74B
ATAI Life Sciences is a biotech company developing psychedelic and non-psychedelic compounds for mental health disorders, overlapping with Entheon's market.
GH Research
GHRS
Mkt Cap1.94B
GH Research focuses on developing 5-MeO-DMT therapies for depression, a direct competitor in the psychedelic treatment space.
Nuveen Municipal Income
NUMI
Mkt Cap0
Numinus Wellness focuses on psychedelic production and therapy, directly competing with Entheon's business model in mental health.
Revive Therapeutics
RVVTF
Mkt Cap9.15M
Revive Therapeutics explores psilocybin-based therapies, which is a direct competition to Entheon's psychedelic research and development.
Noveris Health Sciences
MYCOF
Mkt Cap64.4M
Mydecine Innovations Group focuses on developing and commercializing psychedelic medicines, competing in the same niche as Entheon.

About

ENTHEON BIOMEDICAL CORP
Show more...
CEO
Country
Canada
ISIN
CA29383X1033
WKN
000A404YT

Listings

F
DE
1XU.F
CN
CA
ENBI-X.CN
STU
DE
1XU.STU
MU
DE
1XU1.MU

0 Comments

Share your thoughts

FAQ

What is Entheon Biomedical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Entheon Biomedical stocks are traded under the ticker 1XU1.MU.
What is Entheon Biomedical revenue for the last year?▼
Entheon Biomedical revenue for the last year amounts to 0 EUR.
What is Entheon Biomedical net income for the last year?▼
1XU1.MU net income for the last year is -208,951.29 EUR.
In which sector is Entheon Biomedical located?▼
Entheon Biomedical operates in the Other sector.
When did Entheon Biomedical complete a stock split?▼
The last stock split for Entheon Biomedical was on March 01, 2024 with a ratio of 1:10.